SanBio Company Limited
Other OTCTotal Valuation
SanBio Company Limited carries a market capitalization of 1.28B, placing it among publicly traded companies globally. Its enterprise value stands at 36.89B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.28B |
| Enterprise Value | 36.89B |
Share Statistics
SanBio Company Limited currently has 68.63M shares outstanding.
| Shares Outstanding | 68.63M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | 16.64 |
| P/TBV Ratio | 25.81 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
| EV / Sales | N/A |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 3,462.52 |
Financial Position
SanBio Company Limited maintains a current ratio of 5.30, meaning it holds 5.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 33.78, indicating elevated leverage, while an interest coverage ratio of -329.17 demonstrates limited ability to service its debt obligations.
| Current Ratio | 5.30 |
| Quick Ratio | 4.75 |
| Debt / Equity | 33.78 |
| Debt / EBITDA | -0.18 |
| Interest Coverage | -329.17 |
Financial Efficiency
| Return on Equity (ROE) | -121.77 |
| Return on Assets (ROA) | -51.36 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | -848.06 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
Over the trailing twelve months, SanBio Company Limited has paid 296.50M in income taxes, reflecting an effective tax rate of 440.59.
| Income Tax | 296.50M |
| Effective Tax Rate | 440.59 |
Stock Price Statistics
SanBio Company Limited's stock has gained approximately 151.14504% over the past 52 weeks. The 50-day moving average sits at 16.45, while the 200-day moving average is 16.45.
| Beta (5Y) | N/A |
| 52-Week Price Change | 151.14504% |
| 50-Day Moving Average | 16.45 |
| 200-Day Moving Average | 16.45 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -3.03B, while operating income came in at -3.03B.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -3.03B |
| Pretax Income | -1.87B |
| Net Income | -2.17B |
| EBITDA | -3.03B |
| EBIT | -3.03B |
| Earnings Per Share (EPS) | -31.70 |
Balance Sheet
SanBio Company Limited holds 3.08B in cash and equivalents against 531.00M in total debt, resulting in a net debt position of -2.55B. Total book value stands at 2.37B, with working capital of 2.79B providing operational flexibility.
| Cash & Cash Equivalents | 3.08B |
| Total Debt | 531.00M |
| Net Debt | -2.55B |
| Equity (Book Value) | 2.37B |
| Book Value Per Share | 34.69 |
| Working Capital | 2.79B |
Scores
SanBio Company Limited posts an Altman Z-Score of 10.37, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 10.37 |